Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg and Neurotechnology by Year
MedSurg and Neurotechnology — Segment Operating Income ($M) ($M)
Stryker MedSurg and Neurotechnology: $4,672M in FY2025, up 16.7% from a year earlier.
Latest, FY2025
4,672
Period ended Dec 31, 2025
Change on a year earlier
+16.7%
4,004 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MedSurg and Neurotechnology — Segment Operating Income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,672 | +16.7% | Stryker Form 10-K — FY2025 (filed 2026-02-11) ↗ |
| FY2024 | Dec 31, 2024 | 4,004 | +15.4% | Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 3,470 | +22.6% | Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 2,831 | +0.9% | Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗ |
| FY2021 | Dec 31, 2021 | 2,807 | +16.3% | Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗ |
| FY2020 | Dec 31, 2020 | 2,414 | +4.8% | Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 2,304 | – | Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗ |
Cite this data
StockData. (2026). Stryker MedSurg and Neurotechnology ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/db-seg-ms-opinc
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.